Patents by Inventor Phillip David Monk

Phillip David Monk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN ANTIBODY MOLECULES FOR IL-13
    Publication number: 20180230209
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: November 27, 2017
    Publication date: August 16, 2018
    Inventors: Phillip David MONK, Lutz JERMUTUS, Celia Patricia SHORROCK, Ralph Raymond MINTER
  • Human antibody molecules for IL-13
    Patent number: 9856317
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: January 2, 2018
    Assignee: MEDIMMUNE LIMITED
    Inventors: Phillip David Monk, Lutz Jermutus, Celia Patricia Shorrock, Ralph Raymond Minter
  • HUMAN ANTIBODY MOLECULES FOR IL-13
    Publication number: 20160280779
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: March 2, 2016
    Publication date: September 29, 2016
    Inventors: Phillip David MONK, Lutz JERMUTUS, Celia Patricia SHORROCK, Ralph Raymond MINTER
  • Therapy for influenza like illness
    Patent number: 9421243
    Abstract: An agent selected from: (a) interferon-? (IFN-?); (b) an agent that increases IFN-? expression; or (c) a polynucleotide which is capable of expressing (a) or (b); for use in the treatment of individuals with lower respiratory tract illness that has developed during or following an established ILI, wherein said treatment is by airway delivery of said medicament.
    Type: Grant
    Filed: March 10, 2011
    Date of Patent: August 23, 2016
    Assignee: SYNAIRGEN RESEARCH LIMITED
    Inventors: Victoria Jane Tear, James Jonathan Welch Roberts, Phillip David Monk
  • Methods of treatment using human antibody molecules for IL-13
    Patent number: 9315575
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralise IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: November 8, 2010
    Date of Patent: April 19, 2016
    Assignee: MEDIMMUNE LIMITED
    Inventors: Phillip David Monk, Lutz Jermutus, Celia Patricia Shorrock, Ralph Raymond Minter
  • THERAPY FOR INFLUENZA LIKE ILLNESS
    Publication number: 20130064792
    Abstract: An agent selected from: (a) interferon-? (IFN-?); (b) an agent that increases IFN-? expression; or (c) a polynucleotide which is capable of expressing (a) or (b); for use in the treatment of individuals with lower respiratory tract illness that has developed during or following an established ILI, wherein said treatment is by airway delivery of said medicament.
    Type: Application
    Filed: March 10, 2011
    Publication date: March 14, 2013
    Inventors: Victoria Jane Tear, James Jonathan Welch Roberts, Phillip David Monk
  • Human Antibody Molecules For IL-13
    Publication number: 20120052060
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralise IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: November 8, 2010
    Publication date: March 1, 2012
    Applicant: MedImmune Limited
    Inventors: Phillip David Monk, Lutz Jermutus, Celia Patricia Shorrock, Ralph Raymond Minter
  • Binding members for IgE molecules
    Patent number: 7959917
    Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
    Type: Grant
    Filed: February 15, 2008
    Date of Patent: June 14, 2011
    Assignee: MedImmune Limited
    Inventors: Duncan Cochrane, Suzanne Cohen, Claire Louise Dobson, Per-Olof Eriksson, Karin Von Wachenfeldt, Phillip David Monk
  • Human antibody molecules for IL-13
    Patent number: 7947273
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralise IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: June 25, 2007
    Date of Patent: May 24, 2011
    Assignee: MedImmune Limited
    Inventors: Phillip David Monk, Lutz Jermutus, Celia Patricia Shorrock, Ralph Raymond Minter
  • Human antibody molecules for IL-13
    Patent number: 7935343
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralize IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: May 3, 2011
    Assignee: MedImmune Limited
    Inventors: Phillip David Monk, Lutz Ulrich Jochen Jermutus, Ralph Raymond Minter, Celia Patricia Shorrock
  • Human antibody molecules for IL-13
    Patent number: 7829090
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralise IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: November 9, 2010
    Assignee: MedImmune Limited
    Inventors: Phillip David Monk, Lutz Jermutus, Celia Patricia Shorrock, Ralph Raymond Minter
  • Human antibody molecules for IL-13
    Publication number: 20090123478
    Abstract: Specific binding members, in particular human anti-IL-13 antibody molecules and especially those which neutralise IL-13 activity. Methods for using anti-IL-13 antibody molecules in diagnosis or treatment of IL-13 related disorders, including asthma, atopic dermatitis, allergic rhinitis, fibrosis, inflammatory bowel disease and Hodgkin's lymphoma.
    Type: Application
    Filed: June 25, 2007
    Publication date: May 14, 2009
    Inventors: Phillip David Monk, Lutz Jermutus, Celia Patricia Shorrock, Ralph Raymond Minter
  • BINDING MEMBERS FOR IgE MOLECULES
    Publication number: 20090060919
    Abstract: This invention relates to binding members, especially antibody molecules, for IgE. The binding members are useful for, inter alia, treatment of disorders mediated by IgE including allergies and asthma.
    Type: Application
    Filed: February 15, 2008
    Publication date: March 5, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Duncan Cochrane, Suzanne Cohen, Claire Louise Dobson, Per-Olof Eriksson, Karin Von Wachenfeldt, Phillip David Monk